###############################################################################
# FILE: TS_map.ttl
# DESC: Stardog SMS Template file for mapping TS to graph.
# REQ : File format requirements for both execution and consistent processing
#         by visualization scripts:
#         s line is hard left on line by itself
#         p,o line - indented at least one space.
#                  - ends in ; on same line, no trailing spaces
#         p : no short hand: 'rdf:type', not 'a'
#         File must end with carriage return on a line by itself.
# SRC :
# IN  : CSV converted from TS.XPT. First row only
# OUT :
# NOTE: stardog-admin virtual import CTDasRDF TS_mappings.TTL TS_subset.csv
#  Export to TTL: stardog data export --format TURTLE CTDasRDF C:/temp/test.ttl
# TODO:
###############################################################################

@prefix cd01p: <https://w3id.org/phuse/cd01p#> .
@prefix cdiscpilot01: <https://w3id.org/phuse/cdiscpilot01#> .
@prefix prot: <https://w3id.org/phuse/prot#> .
@prefix code: <https://w3id.org/phuse/code#> .
@prefix custom: <https://w3id.org/phuse/custom#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix sdtmterm: <https://w3id.org/phuse/sdtmterm#> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix study: <https://w3id.org/phuse/study#> .
@prefix time: <http://www.w3.org/2006/time#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .


prot:Study_CDISCPILOT01
  rdf:type                            study:Study;
  skos:prefLabel                      "Study: CDISCPILOT01"^^xsd:string ;
  study:narms                         "3"^^xsd:int;
  study:adaptiveDesign                sdtmterm:NoYesResponse_N ;
  study:hasTitle                      prot:Title_CDISCPILOT01;
  study:hasPrimObjective              prot:PrimaryObjective_CDISCPILOT01_001;
  study:hasPrimObjective              prot:PrimaryObjective_CDISCPILOT01_002;
  study:hasSecObjective               prot:SecondaryObjective_CDISCPILOT01_001;
  study:hasSecObjective               prot:SecondaryObjective_CDISCPILOT01_002;
  study:hasSecObjective               prot:SecondaryObjective_CDISCPILOT01_003;
  study:hasSecObjective               prot:SecondaryObjective_CDISCPILOT01_004;
  study:hasPopulation                 prot:EnrolledPopulation_CDISCPILOT01;
  study:hasPopulation                 prot:StudyPopulation_CDISCPILOT01;
.

prot:Title_CDISCPILOT01
  rdf:type                            study:Title;
  study:longTitle                     "Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimer’s Disease."^^xsd:string ;
.
  
prot:PrimaryObjective_CDISCPILOT01_001
  rdf:type                            study:PrimaryObjective;
  skos:prefLabel										  "To determine if there is a statistically significant relationship between the change in both ADAS-Cog and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])"^^xsd:string ;
.

prot:PrimaryObjective_CDISCPILOT01_002
  rdf:type                            study:PrimaryObjective;
  skos:prefLabel										  "To document the safety profile of the xanomeline TTS."^^xsd:string ;
.

prot:SecondaryObjective_CDISCPILOT01_001
  rdf:type                            study:SecondaryObjective;
  skos:prefLabel										  "To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these areas."^^xsd:string ;
.

prot:SecondaryObjective_CDISCPILOT01_002
  rdf:type                            study:SecondaryObjective;
  skos:prefLabel										  "To assess the dose-dependent improvements in activities of daily living. Improved scores on the Disability Assessment for Dementia (DAD) will indicate improvement in these areas."^^xsd:string ;
.


prot:SecondaryObjective_CDISCPILOT01_003
  rdf:type                            study:SecondaryObjective;
  skos:prefLabel										  "To assess the dose-dependent improvements in an extended assessment of cognition that integrates attention/concentration tasks. The ADAS-Cog (14) will be used for this assessment."^^xsd:string ;
.


prot:SecondaryObjective_CDISCPILOT01_004
  rdf:type                            study:SecondaryObjective;
  skos:prefLabel										  "To assess the treatment response as a function of Apo E genotype."^^xsd:string ;
.